| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +0.98% | +0.18% | +0.81% | +0.81% | — |
| 14d | 2 | +50.00% | -6.56% | +2.43% | -8.99% | -8.99% | — |
| 30d | 2 | +50.00% | -7.27% | +4.75% | -12.02% | -12.02% | — |
| 60d | 2 | +50.00% | -8.22% | +7.69% | -15.91% | -15.91% | — |
| 90d | 2 | +50.00% | -10.58% | +8.78% | -19.36% | -19.36% | — |
| 180d | 2 | +50.00% | -14.20% | +15.85% | -30.05% | -30.05% | — |
| 1y | 2 | +50.00% | -11.35% | +25.55% | -36.91% | -36.91% | — |
| 2y | 2 | +50.00% | -19.09% | +12.67% | -31.76% | -31.76% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 97,446 | $56.50 | $5.51M | 461,953 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 600 | $57.09 | $34.3K | 40,000 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 2,554 | $57.10 | $145.8K | 459,399 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 29,400 | $56.44 | $1.66M | 40,600 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 32,408 | $54.11 | $1.75M | 676,991 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE10b5-1 10b5-1 plan | 117,592 | $54.47 | $6.41M | 559,399 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 24,263 | — | — | 709,399 | May 6, 2026 | May 8, 2026 ↗ | View → |
| KLRA KAILERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,300 | — | — | 38,300 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| VERA VERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,937 | — | — | 24,937 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 26,626 | — | — | 685,136 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 6,168 | — | — | 658,510 | Nov 5, 2025 | Nov 7, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 3,696 | — | — | 652,342 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 1,238,789 | — | — | 1,238,789 | May 16, 2025 | May 20, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 48,646 | — | — | 648,646 | May 8, 2025 | May 9, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE EVP & Vice Chairman | 30,000 | — | — | 86,641 | Feb 14, 2025 | Feb 18, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASE EVP & Vice Chairman | 300,000 | — | — | 600,000 | Feb 14, 2025 | Feb 18, 2025 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE EVP & Vice Chairman | 30,000 | — | — | 541 | May 13, 2024 | May 16, 2024 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASE EVP & Vice Chairman | 300,000 | — | — | 370,000 | May 13, 2024 | May 16, 2024 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | SALE EVP & Vice Chairman | 31,959 | $469.86 | $15.02M | 30,541 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASE EVP & Vice Chairman | 70,000 | $28.00 | $1.96M | 70,000 | Jun 18, 2020 | Jun 23, 2020 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 116,100 | — | — | 116,100 | Jun 15, 2020 | Jun 23, 2020 ↗ | View → |
| RPRX ROYALTY PHARMA PLC | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | Jun 15, 2020 | Jun 23, 2020 ↗ | View → |